Trade BMRN stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
BioMarin Pharmaceutical Inc. (BMRN) is trading at US$63.37, down 1.08% today as of Sep 22, 16:00 EDT. The company has a market capitalisation of US$12.91B. Over the past 52 weeks, BMRN has traded between US$49.26 and US$70.98. On Syfe you can trade BMRN with $0 commission and add it to your watchlist.
| Previous close | US$64.06 |
|---|---|
| Market cap | US$12.91B |
| P/E ratio | 10.23 |
| 52-week range | US$49.26 – US$70.98 |
| Volume | 1.96M |
| Exchange | US |
Add to Watchlist
Set Price Alert
BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical, Inc. is a global rare disease biotechnology company focused on delivering medicines for people living with genetically defined conditions. The company has a proven track record of innovation, with nine commercial therapies and a strong clinical and preclinical pipeline. Using a distinctive approach to drug discovery and development, BioMarin seeks to unleash the full potential of genetic science by pursuing category-defining medicines that have a profound impact on patients. The company was founded by John C. Klock, Christopher M. Starr and Grant W. Denison on March 21, 1997 and is headquartered in San Rafael, CA.
Year: 1999
BioMarin Pharmaceutical's Alesta Deal Strengthens Long-Term Growth Outlook, Wedbush Says
Aug 18, 3:25 PM · MT Newswires
BioMarin Pharmaceutical to Acquire Alesta Therapeutics for up to $490 Million
Aug 18, 1:01 PM · MT Newswires
BioMarin Lifts 2026 Outlook on Strong Voxzogo Sales, Wedbush Says
Aug 7, 3:44 PM · MT Newswires
Oppenheimer Adjusts PT on BioMarin Pharmaceutical to $97 From $95, Maintains Outperform Rating
Aug 7, 1:16 PM · MT Newswires
BioMarin Pharmaceutical Inc. (BMRN) stock is trading at US$63.37, -1.08% from the previous close of US$64.06.
The market cap for BioMarin Pharmaceutical Inc. (BMRN) stock is approximately US$12.91B.
The price-to-earnings ratio for BioMarin Pharmaceutical Inc. (BMRN) is 10.23, based on the latest reported earnings.
The 52-week high for BioMarin Pharmaceutical Inc. (BMRN) stock is US$70.98.
The 52-week low for BioMarin Pharmaceutical Inc. (BMRN) stock is US$49.26.
BioMarin Pharmaceutical Inc. (BMRN) does not currently pay a dividend.
Stay on top of BMRN
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
